Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis

• Status: Unknown status
• Trial end date: 2020-05-01

Summary

Henoch-Schonlein purpura nephritis(HSPN) is one of the most common secondary glomerulonephritis in children. A large, prospective, multicenter cohort study is being conducted in three institutions. Eligible Henoch-Schönlein purpura nephritis children will be classified as the experimental group (n=300) and the control group (n=300) based on the interventions they receive. Patients taking Chinese herbal formula will be in the experimental group, and those taking Western medicine will be in the control group. The entire study will last 60 weeks, including a 12-week observation period and a followup at 12 months.

Details

• Lead Sponsor: Liaoning University of Traditional Chinese Medicine
• Collaborators: First Hospital of China Medical University; Shengjing Hospital
• Treatments: Adrenergic Agents; Adrenocorticotropic Hormone; Angiotensin-Converting Enzyme Inhibitors; beta-Endorphin; Cardiac Glycosides; Enzyme Inhibitors; Hormones; Immunosuppressive Agents; Melanocyte-Stimulating Hormones